These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
393 related items for PubMed ID: 32880785
41. NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas-a study of 4569 cases. Chou A, Fraser T, Ahadi M, Fuchs T, Sioson L, Clarkson A, Sheen A, Singh N, Corless CL, Gill AJ. Mod Pathol; 2020 May; 33(5):924-932. PubMed ID: 31792356 [Abstract] [Full Text] [Related]
42. Evaluation of NTRK expression and fusions in a large cohort of early-stage lung cancer. Dyrbekk APH, Warsame AA, Suhrke P, Ludahl MO, Zecic N, Moe JO, Lund-Iversen M, Brustugun OT. Clin Exp Med; 2024 Jan 19; 24(1):10. PubMed ID: 38240952 [Abstract] [Full Text] [Related]
43. Novel TG-FGFR1 and TRIM33-NTRK1 transcript fusions in papillary thyroid carcinoma. Pfeifer A, Rusinek D, Żebracka-Gala J, Czarniecka A, Chmielik E, Zembala-Nożyńska E, Wojtaś B, Gielniewski B, Szpak-Ulczok S, Oczko-Wojciechowska M, Krajewska J, Polańska J, Jarząb B. Genes Chromosomes Cancer; 2019 Aug 19; 58(8):558-566. PubMed ID: 30664823 [Abstract] [Full Text] [Related]
44. An evaluation and recommendation of the optimal methodologies to detect RET gene rearrangements in papillary thyroid carcinoma. Zhang T, Lu Y, Ye Q, Zhang M, Zheng L, Yin X, Gavine P, Sun Z, Ji Q, Zhu G, Su X. Genes Chromosomes Cancer; 2015 Mar 19; 54(3):168-76. PubMed ID: 25407564 [Abstract] [Full Text] [Related]
45. Specific immunohistochemical detection of the BRAF V600E mutation in primary and metastatic papillary thyroid carcinoma. Zhu X, Luo Y, Bai Q, Lu Y, Lu Y, Wu L, Zhou X. Exp Mol Pathol; 2016 Feb 19; 100(1):236-41. PubMed ID: 26795218 [Abstract] [Full Text] [Related]
46. A Shift in Molecular Drivers of Papillary Thyroid Carcinoma Following the 2017 World Health Organization Classification: Characterization of 554 Consecutive Tumors With Emphasis on BRAF-Negative Cases. Hang JF, Chen JY, Kuo PC, Lai HF, Lee TL, Tai SK, Kuo CS, Chen HS, Li WS, Li CF. Mod Pathol; 2023 Sep 19; 36(9):100242. PubMed ID: 37307878 [Abstract] [Full Text] [Related]
52. Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET, in Thyroid Cancers of Young Patients in Fukushima. Iyama K, Matsuse M, Mitsutake N, Rogounovitch T, Saenko V, Suzuki K, Ashizawa M, Ookouchi C, Suzuki S, Mizunuma H, Fukushima T, Suzuki S, Yamashita S. Thyroid; 2017 Jun 19; 27(6):811-818. PubMed ID: 28351223 [Abstract] [Full Text] [Related]
53. ETV6-NTRK3 and STRN-ALK kinase fusions are recurrent events in papillary thyroid cancer of adult population. Bastos AU, de Jesus AC, Cerutti JM. Eur J Endocrinol; 2018 Jan 19; 178(1):83-91. PubMed ID: 29046324 [Abstract] [Full Text] [Related]
57. NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma. Rabban JT, Devine WP, Sangoi AR, Poder L, Alvarez E, Davis JL, Rudzinski E, Garg K, Bean GR. Histopathology; 2020 Jul 19; 77(1):100-111. PubMed ID: 31971278 [Abstract] [Full Text] [Related]